Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED Actual shortage 2MG 0.5MG Updated Report 2024-05-03 221534
TEVA-BUPROPION XL TEVA CANADA LIMITED Actual shortage 150MG Updated Report 2024-05-03 225492
ACT CLARITHROMYCIN XL TEVA CANADA LIMITED Actual shortage 500MG Updated Report 2024-05-03 215737
TEVA-CLOPIDOGREL TEVA CANADA LIMITED Actual shortage 300MG Updated Report 2024-05-03 212720
TEVA-TELMISARTAN HCTZ TEVA CANADA LIMITED Actual shortage 25.0MG 80.0MG Updated Report 2024-05-03 224901
CIPROFLOXACIN SANIS HEALTH INC Actual shortage 500MG Updated Report 2024-05-03 211200
!!T3 TEVA-TAMSULOSIN CR TEVA CANADA LIMITED Actual shortage 0.4MG Updated Report 2024-05-03 209148
!!T3 TEVA-TAMSULOSIN CR TEVA CANADA LIMITED Actual shortage 0.4MG Updated Report 2024-05-03 190785
TEVA-VALACYCLOVIR TEVA CANADA LIMITED Actual shortage 500MG Updated Report 2024-05-03 225489
TEVA-DONEPEZIL TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-03 222941

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
AUBAGIO SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC To be discontinued 14MG New Report 2024-05-02 226847
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226748
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226753
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-05-02 224344
SANDOZ D 10 000 SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-02 226738